Wixela Inhub FDA Approval History
FDA Approved: Yes (First approved January 30, 2019)
Brand name: Wixela Inhub
Generic name: fluticasone propionate and salmeterol
Dosage form: Inhalation Powder
Company: Mylan N.V.
Treatment for: Asthma, COPD
Wixela Inhub is the first approved generic version of Advair Diskus.
Development Timeline for Wixela Inhub
|Jan 31, 2019||ApprovalFDA Approves Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), First Generic of Advair Diskus|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.